Gm711 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Gm711 gene, a relatively unknown gene with potential roles in fundamental cellular processes such as gene regulation, intracellular signaling, and protein interactions. Although the precise biological functions of Gm711 are not well-defined, it is likely involved in pathways that govern transcriptional regulation, cellular differentiation, and the maintenance of cellular homeostasis. Like many genes that have yet to be fully characterized, Gm711 may interact with various regulatory proteins and play a role in controlling key cellular mechanisms, such as the modulation of gene expression in response to environmental stimuli or during developmental processes. By inhibiting Gm711, researchers can explore its specific functions within these broader biological networks, providing insights into how it influences cellular behavior and maintains the balance of essential cellular functions.
In research contexts, Gm711 inhibitors offer an important tool for studying the molecular pathways regulated by Gm711 and its role in cellular dynamics. By blocking Gm711 activity, scientists can observe the downstream effects on gene expression profiles, protein-protein interactions, and intracellular signaling pathways, offering clues into the gene's broader role in cellular processes. This inhibition enables researchers to investigate how Gm711 influences critical functions such as cell growth, differentiation, and response to stress signals, and how disruptions in Gm711 activity might affect these processes. Furthermore, Gm711 inhibitors provide insight into the complex interactions between Gm711 and other proteins or regulatory molecules, helping to map out its place within the intricate networks that control cellular behavior. Through these studies, the use of Gm711 inhibitors contributes to a deeper understanding of gene regulation and the molecular mechanisms that govern essential biological functions, particularly for genes that have not been extensively studied.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a broad spectrum of kinases and can indirectly affect STKLD1 by modulating kinase-dependent signaling pathways. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine kinase inhibitor that can influence cellular ATP levels, thus potentially affecting ATP-dependent kinases similar to STKLD1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can alter stress-activated protein kinase pathways, potentially affecting the regulation of STKLD1 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C inhibitor that can modify the PKC-mediated signaling, which could impact STKLD1 if it is downstream or part of a PKC-regulated pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can change the PI3K/Akt signaling pathway, potentially influencing STKLD1 activity if it is regulated by this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that can disrupt the MAPK/ERK pathway, possibly affecting STKLD1 activity if STKLD1 is modulated by this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can modify the p38 pathway, potentially altering STKLD1 activity if there is a regulatory connection. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can also disturb the PI3K/Akt pathway and indirectly influence STKLD1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect the mTOR signaling pathway, which might alter the activity of STKLD1 through indirect regulatory mechanisms. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
An Src family kinase inhibitor that can modify Src-dependent signaling, potentially impacting STKLD1 if it is associated with Src-regulated pathways. | ||||||